IL165216A0 - Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives - Google Patents

Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives

Info

Publication number
IL165216A0
IL165216A0 IL16521603A IL16521603A IL165216A0 IL 165216 A0 IL165216 A0 IL 165216A0 IL 16521603 A IL16521603 A IL 16521603A IL 16521603 A IL16521603 A IL 16521603A IL 165216 A0 IL165216 A0 IL 165216A0
Authority
IL
Israel
Prior art keywords
vinlafaxin
genitouririnary
derivatives
methods
pain disorders
Prior art date
Application number
IL16521603A
Other languages
English (en)
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of IL165216A0 publication Critical patent/IL165216A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/275—Nitriles; Isonitriles
    • A61K31/277—Nitriles; Isonitriles having a ring, e.g. verapamil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL16521603A 2002-05-17 2003-05-15 Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives IL165216A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38130502P 2002-05-17 2002-05-17
PCT/US2003/015230 WO2003097029A1 (en) 2002-05-17 2003-05-15 Methods of treating gastrointestinal and genitourinary pain disorders using vinlafaxin and derivatives

Publications (1)

Publication Number Publication Date
IL165216A0 true IL165216A0 (en) 2005-12-18

Family

ID=29550101

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16521603A IL165216A0 (en) 2002-05-17 2003-05-15 Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives

Country Status (21)

Country Link
US (1) US20040019101A1 (pt)
EP (1) EP1505960A1 (pt)
JP (1) JP2005530779A (pt)
KR (1) KR20050003464A (pt)
CN (1) CN1652758A (pt)
AR (1) AR040033A1 (pt)
AU (1) AU2003232137A1 (pt)
BR (1) BR0310083A (pt)
CA (1) CA2485736A1 (pt)
CR (1) CR7568A (pt)
EC (1) ECSP045436A (pt)
IL (1) IL165216A0 (pt)
MX (1) MXPA04011329A (pt)
NO (1) NO20044868L (pt)
NZ (1) NZ548950A (pt)
RU (1) RU2004136999A (pt)
SG (1) SG165991A1 (pt)
TW (1) TW200402289A (pt)
UA (1) UA81413C2 (pt)
WO (1) WO2003097029A1 (pt)
ZA (1) ZA200410157B (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7365076B2 (en) 2003-10-14 2008-04-29 Wyeth Substituted aryl cycloalkanol derivatives and methods of their use
US7419980B2 (en) * 2003-10-14 2008-09-02 Wyeth Fused-aryl and heteroaryl derivatives and methods of their use
US7491723B2 (en) * 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use
US7402698B2 (en) * 2003-10-14 2008-07-22 Wyeth Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
US7531543B2 (en) * 2003-10-14 2009-05-12 Wyeth Phenylpiperazine cycloalkanol derivatives and methods of their use
US7550485B2 (en) * 2003-10-14 2009-06-23 Wyeth Substituted N-heterocycle derivatives and methods of their use
US7524846B2 (en) * 2003-10-14 2009-04-28 Wyeth Arylalkyl- and cycloalkylalkyl-piperazine derivatives and methods of their use
US20060148781A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder in a non-human mammal
US20060148782A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating a mammal presenting urinary incontinence, urinary urgency, or both
US20050113365A1 (en) * 2003-11-10 2005-05-26 Sir Isaac Newton Enterprises Llc Method and medicine for treating gastrointestinal disorder including irritable bowel syndrome
US20070142367A1 (en) * 2003-11-10 2007-06-21 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US20060148783A1 (en) * 2003-11-10 2006-07-06 Lundeen James E Method and medicine for treating gastrointestinal disorder including fecal incontinence
US7820690B2 (en) * 2004-03-19 2010-10-26 Solvay Pharmaceuticals Gmbh Method of treating or inhibiting a non-digestive tract derived abdominal disorder associated with pain using a 5-HT, receptor antagonist
US7517899B2 (en) * 2004-03-30 2009-04-14 Wyeth Phenylaminopropanol derivatives and methods of their use
US7414052B2 (en) * 2004-03-30 2008-08-19 Wyeth Phenylaminopropanol derivatives and methods of their use
US20080081067A1 (en) * 2006-10-03 2008-04-03 Gupta Manishkumar Sustained release pharmaceutical compositions of venlafaxine and process for preparation thereof
GB201007032D0 (en) * 2010-04-27 2010-06-09 Dormer Tools Ltd Twist drill for advanced materials
CN102095461B (zh) * 2011-01-18 2012-07-18 姚贤卿 复合型干度质量流量仪及干度标定测量方法
RU2740750C1 (ru) * 2020-03-27 2021-01-20 Аллан Герович Бениашвили Средство для лечения функциональных заболеваний желудочно-кишечного тракта

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535186A (en) * 1983-04-19 1985-08-13 American Home Products Corporation 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives
ATE250931T1 (de) * 1996-02-15 2003-10-15 Janssen Pharmaceutica Nv Verwendung von 5-ht4 antagonisten zur überwindung der gastrointestinalen beschädigung, die durch inhibitoren der serotonin-wiederaufnahme hervorgerufen werden
US6579899B1 (en) * 1998-07-16 2003-06-17 Massachusetts Institute Of Technology Composition for treatment of stress
ATE253364T1 (de) * 1998-11-23 2003-11-15 Sepracor Inc Olanzapin-n-oxide enthaltende pharmaceutische zusammensetzungen
AU757973B2 (en) * 1998-11-23 2003-03-13 Sepracor, Inc. Desmethylolanzapine compositions and methods
US6174882B1 (en) * 1998-11-23 2001-01-16 Sepracor Inc. 2-hydroxymethylolanzapine compositions and methods
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB2355191A (en) * 1999-10-12 2001-04-18 Laxdale Ltd Combination formulations for fatigue, head injury and strokes
AU2003225206B2 (en) * 2002-04-24 2008-02-14 Forest Laboratories Holdings Limited Prevention and treatment of functional somatic disorders, including stress-related disorders
AU2003247515A1 (en) * 2002-06-10 2003-12-22 Wyeth Novel formate salt of o-desmethyl-venlafaxine

Also Published As

Publication number Publication date
ZA200410157B (en) 2006-05-31
BR0310083A (pt) 2005-02-15
CN1652758A (zh) 2005-08-10
EP1505960A1 (en) 2005-02-16
NO20044868L (no) 2004-12-08
TW200402289A (en) 2004-02-16
KR20050003464A (ko) 2005-01-10
CR7568A (es) 2005-02-08
SG165991A1 (en) 2010-11-29
NZ548950A (en) 2008-01-31
CA2485736A1 (en) 2003-11-27
MXPA04011329A (es) 2005-02-14
JP2005530779A (ja) 2005-10-13
WO2003097029A1 (en) 2003-11-27
RU2004136999A (ru) 2006-06-10
AR040033A1 (es) 2005-03-09
AU2003232137A1 (en) 2003-12-02
UA81413C2 (en) 2008-01-10
ECSP045436A (es) 2005-01-03
US20040019101A1 (en) 2004-01-29

Similar Documents

Publication Publication Date Title
EP1509279A4 (en) DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES
IL210091A0 (en) TREATMENT OF TNFa RELATED DISORDERS
AU5714601A (en) Methods for prevention and treatment of gastrointestinal disorders
HK1089155A1 (en) Novel cyanopyridine derivatives useful in the treatment of cancer and other disorders
IL165216A0 (en) Methods of treating gastrointestinal and genitouririnary pain disorders using vinlafaxin and derivatives
AU2003290548A8 (en) Prevention and treatment of synucleinopathic disease
HK1079203A1 (en) Substituted amine derivatives and methods of use in the treatment of angiogenesis related disorders
EP1489915A4 (en) TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
ZA200410409B (en) Use of thio-oxindole derivatives in treatment of hormonerelated conditions
IL165394A0 (en) Use of thio-oxindole derivatives in treatment of skin disorders
AU2003287909A8 (en) Electro-therapeutic device and method of electro-therapeutic treatment
PL378465A1 (pl) Sposób i urządzenie do terapii leczniczej
PL376894A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
HK1076468A1 (en) Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof
AU2003272728A8 (en) Methods and compositions for treatment of neurological disorder
GB0213869D0 (en) The treatment of pain
PL376895A1 (pl) Pochodne 4-(fenylopiperazynylometylo) benzamidu i ich zastosowanie do leczenia bólu lub zaburzeń żołądkowo-jelitowych
GB0211295D0 (en) Treatment of pain
IL166062A0 (en) Compositions and methods for therapeutic treatment
EP1539100A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
AU2003270540A8 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
GB0221712D0 (en) Methods of treatment
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
IL166083A0 (en) Methods for treatment and prevention of gastrointestinal conditions
AU2003270622A8 (en) Methods of diagnosing and treating hyperproliferative disorders